Outcomes of preconditioning regimen with total body irradiation in treating T-cell lymphoma
Biao Wang
Abstract
Biao Wang
Abstract
Objective To investigate the clinical efficacy and safety of total body irradiation(TBI)-predominant preconditioning regimen in patients with T-cell lymphoma.Methods Data of 12 patients with T-cell lymphoma were retrospectively analyzed,who underwent TBI-predominant preconditioning regimen after autologous hematopoietic stem cell transplantation(AHSCT).The hematopoietic reconstitution,complications and survival were followed up.Results The hematopoietic reconstitution was successful.The time for ANC ≥0.5×109/L was 10-15 days and the time for platelet counts ≥20×109/L was 11-16 days after successful hematopoietic reconstitution.The patients were followed-up for 8-60 months with the recurrence rate of 25%(3/12),mortality rate of 16.7%(2/12),and 2-year disease-free survival rate of 75%(9/12).Conclusion The TBI-predominant preconditioning regimen is effective and safe in the treatment of T-cell lymphoma.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the clinical efficacy and safety of total body irradiation(TBI)-predominant preconditioning regimen in patients with T-cell lymphoma.Methods Data of 12 patients with T-cell lymphoma were retrospectively analyzed,who underwent TBI-predominant preconditioning regimen after autologous hematopoietic stem cell transplantation(AHSCT).The hematopoietic reconstitution,complications and survival were followed up.Results The hematopoietic reconstitution was successful.The time for ANC ≥0.5×109/L was 10-15 days and the time for platelet counts ≥20×109/L was 11-16 days after successful hematopoietic reconstitution.The patients were followed-up for 8-60 months with the recurrence rate of 25%(3/12),mortality rate of 16.7%(2/12),and 2-year disease-free survival rate of 75%(9/12).Conclusion The TBI-predominant preconditioning regimen is effective and safe in the treatment of T-cell lymphoma.
Key concepts: Medicine, Total body irradiation, Regimen, Lymphoma, Hematopoietic stem cell transplantation, Internal medicine, Hematopoietic cell, Surgery